Michele G Fojas, NP | |
252 Mchenry St, Burlington, WI 53105-1828 | |
(262) 767-6000 | |
(262) 767-6545 |
Full Name | Michele G Fojas |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Location | 252 Mchenry St, Burlington, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073232799 | NPI | - | NPPES |
100213594 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | 13088 (Wisconsin) | Primary |
Entity Name | Aurora Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Researchers from the Peninsula Medical School, working in collaboration with colleagues from Glasgow Royal Infirmary and the University of Brighton, have used a unique collection of pancreas specimens taken from patients who died soon after diagnosis of type 1 diabetes to show that they respond to the ongoing process of destruction by inducing their islet cells to proliferate.
Brain metastases are a common and dangerous complication in cancer patients. Under the leadership of experts from MedUni Vienna, two of the largest international oncology societies have published new clinical guidelines for the diagnosis and treatment of brain metastases from solid tumors.
As co-director of the University of Alberta's Autism Research Centre, Lonnie Zwaigenbaum has devoted much of his career to understanding how to identify autism as early as possible. But despite his years of experience, Zwaigenbaum says many physicians like him would do well to seek other expert advice when working with children not yet diagnosed-that of the parents of these young patients.
An international team of medical experts led by a Virginia Commonwealth University researcher has established the first clinical guidelines to help improve the diagnosis and treatment of people with normal pressure hydrocephalus, a debilitating condition in the brain that often goes undiagnosed or is misdiagnosed as Alzheimer's or Parkinson's disease.
Active Biotech and Ipsen today presented overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC) at the scientific conference "2012 ASCO Annual Meeting" held in Chicago (USA).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Michele G Fojas, NP 252 Mchenry St, Burlington, WI 53105-1828 Ph: (262) 767-6000 | Michele G Fojas, NP 252 Mchenry St, Burlington, WI 53105-1828 Ph: (262) 767-6000 |
News Archive
Researchers from the Peninsula Medical School, working in collaboration with colleagues from Glasgow Royal Infirmary and the University of Brighton, have used a unique collection of pancreas specimens taken from patients who died soon after diagnosis of type 1 diabetes to show that they respond to the ongoing process of destruction by inducing their islet cells to proliferate.
Brain metastases are a common and dangerous complication in cancer patients. Under the leadership of experts from MedUni Vienna, two of the largest international oncology societies have published new clinical guidelines for the diagnosis and treatment of brain metastases from solid tumors.
As co-director of the University of Alberta's Autism Research Centre, Lonnie Zwaigenbaum has devoted much of his career to understanding how to identify autism as early as possible. But despite his years of experience, Zwaigenbaum says many physicians like him would do well to seek other expert advice when working with children not yet diagnosed-that of the parents of these young patients.
An international team of medical experts led by a Virginia Commonwealth University researcher has established the first clinical guidelines to help improve the diagnosis and treatment of people with normal pressure hydrocephalus, a debilitating condition in the brain that often goes undiagnosed or is misdiagnosed as Alzheimer's or Parkinson's disease.
Active Biotech and Ipsen today presented overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC) at the scientific conference "2012 ASCO Annual Meeting" held in Chicago (USA).
› Verified 2 days ago
Katie Dolezal, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 252 Mchenry St, Burlington, WI 53105 Phone: 262-767-8000 | |
Brian A Schroeder, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 248 Mchenry St, Burlington, WI 53105 Phone: 262-767-8000 | |
Magdalena Anna Horn, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 248 Mchenry St, Burlington, WI 53105 Phone: 262-767-8000 | |
Lisa L Bray, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 709 Spring Valley Rd, Burlington, WI 53105 Phone: 262-971-9200 | |
Corina E Beck, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 248 Mchenry St, Burlington, WI 53105 Phone: 262-741-2734 | |
Ms. Victoria M Bleser, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 248 Mchenry St, Burlington, WI 53105 Phone: 262-767-8259 Fax: 262-767-8212 |